PCR-Based detection and identification of Burkholderiacepacia complex pathogens in sputum from cystic fibrosis patients

McDowell, A., Mahenthiralingam, Eshwar ORCID: https://orcid.org/0000-0001-9014-3790, Moore, J. E., Dunbar, K. E. A., Webb, A. K., Dodd, M. E., Martin, S. L., Millar, B. C., Scott, C. J., Crowe, M. and Elborn, J. S. 2001. PCR-Based detection and identification of Burkholderiacepacia complex pathogens in sputum from cystic fibrosis patients. Journal of Clinical Microbiology 39 (12) , pp. 4247-4255. 10.1128/JCM.39.12.4247-4255.2001

Full text not available from this repository.

Abstract

PCR amplification of the recA gene followed by restriction fragment length polymorphism (RFLP) analysis was investigated for the rapid detection and identification ofBurkholderia cepacia complex genomovars directly from sputum. Successful amplification of the B.cepacia complex recA gene from cystic fibrosis (CF) patient sputum samples containing B.cepacia genomovar I, Burkholderia multivorans, B. cepaciagenomovar III, Burkholderia stabilis, andBurkholderia vietnamiensis was demonstrated. In addition, the genomovar identifications determined directly from sputum were the same as those obtained after selective culturing. Sensitivity experiments revealed thatrecA-based PCR could reliably detect B.cepacia complex organisms to concentrations of 106 CFU g of sputum−1. To fully assess the diagnostic value of the method, sputum samples from 100 CF patients were screened for B. cepacia complex infection by selective culturing and recA-based PCR. Selective culturing identified 19 samples with presumptiveB. cepacia complex infection, which was corroborated by phenotypic analyses. Of the culture-positive sputum samples, 17 were also detected directly by recA-based PCR, while 2 samples were negative. The isolates cultured from bothrecA-negative sputum samples were subsequently identified as Burkholderia gladioli. RFLP analysis of the recA amplicons revealed 2 patients (12%) infected with B. multivorans, 11 patients (65%) infected with B. cepaciagenomovar III-A, and 4 patients (23%) infected with B.cepacia genomovar III-B. These results demonstrate the potential of recA-based PCR-RFLP analysis for the rapid detection and identification of B.cepacia complex genomovars directly from sputum. Where the sensitivity of the assay proves a limitation, sputum samples can be analyzed by selective culturing followed by recA-based analysis of the isolate.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Publisher:	American Society for Microbiology
ISSN:	0095-1137
Last Modified:	27 Oct 2022 09:00
URI:	https://orca.cardiff.ac.uk/id/eprint/64083

Citation Data

Cited 45 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item